Publications

Practical utility of amyloid and FDG-PET in an academic dementia center.

Sánchez-Juan P, Ghosh PM, Hagen J, Gesierich B, Henry M, Grinberg LT, O'Neil JP, Janabi M, Huang EJ, Trojanowski JQ, Vinters HV, Gorno-Tempini M, Seeley WW, Boxer AL, Rosen HJ, Kramer JH, Miller BL, Jagust WJ, Rabinovici GD

2013

In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology.

Caso F, Mandelli ML, Henry M, Gesierich B, Bettcher BM, Ogar J, Filippi M, Comi G, Magnani G, Sidhu M, Trojanowski JQ, Huang EJ, Grinberg LT, Miller BL, Dronkers N, Seeley WW, Gorno-Tempini ML

2013

In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology.

Caso F, Mandelli ML, Henry M, Gesierich B, Bettcher BM, Ogar J, Filippi M, Comi G, Magnani G, Sidhu M, Trojanowski JQ, Huang EJ, Grinberg LT, Miller BL, Dronkers N, Seeley WW, Gorno-Tempini ML

2013

Practical utility of amyloid and FDG-PET in an academic dementia center.

2013

Bidirectional homeostatic plasticity induced by interneuron cell death and transplantation in vivo.

Howard MA, Rubenstein JL, Baraban SC

2013

Bidirectional homeostatic plasticity induced by interneuron cell death and transplantation in vivo.

Howard MA, Rubenstein JL, Baraban SC

2013

Therapeutic modulation of eIF2a phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.

Kim HJ, Raphael AR, LaDow ES, McGurk L, Weber RA, Trojanowski JQ, Lee VM, Finkbeiner S, Gitler AD, Bonini NM

2013